Takahashi, Hideyuki
,
Klein, Zoe A.
Bhagat, Sarah M.
Kaufman, Adam C.
Kostylev, Mikhail A.
Ikezu, Tsuneya
Strittmatter, Stephen M.
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (R01NS074319)
National Institute on Aging (P50AG047270, R01AG034924)
Dr. Ralph and Marian Falk Medical Research Trust
Alzheimer's Association
Article History
Received: 20 September 2016
Revised: 2 January 2017
Accepted: 4 January 2017
First Online: 9 January 2017
Compliance with ethical standards
:
: S.M.S. is a co-founder of Axerion Therapeutics, seeking to develop NgR- and PrP-based therapeutics.